Category: Pakistan

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SES AI Corporation (NYSE: SES) between January 29, 2025 and March 4, 2026, both dates inclusive (the “Class Period”), of the important June 26, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased SES AI securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the SES AI class action, go to https://rosenlegal.com/submit-form/?case_id=56471 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 26, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) SES AI overstated its business prospects by materially overstating the expected results that could be achieved by deals with companies that have limited or no operations; (2) SES AI created an appearance of revenue by purchasing services in exchange for purchases of Molecular Universe; (3) contrary to its positive statements regarding growth prospects, SES AI was affected by material logistics constraints in the fourth quarter of 2025 which would materially affect Q4 2025 revenues; (4) the foregoing called into question SES AI’s growth prospects for 2026, which were confirmed due to lower-than expected 2026 revenue guidance; and (5) as a result, defendants’ statements about SES AI’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the SES AI class action, go to https://rosenlegal.com/submit-form/?case_id=56471 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40^thFloor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9748905

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”), of the important August 3, 2026 lead plaintiff deadline.

SO WHAT: If you purchased GeneDx common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the GeneDx class action, go to https://www.rosenlegal.com/cases/genedx-holdings-corp/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 3, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the claims against defendants arise from their misrepresentations and omissions regarding GeneDx’s statements regarding the impact of Fabric on the overall business of GeneDx. Throughout the Class Period, GeneDx repeatedly made statements that would have caused the average investor to believe that the Fabric acquisition would improve GeneDx’s financials and create efficiencies between it and GeneDx’s core business. These statements include such statements such as: “There is room to run in terms of reducing COGS in the future by combining the best of capability between GeneDx and Fabric as we lean into the best possible algorithms to optimize dry lab processes.” These and similar statements made throughout the Class Period were false. In truth, defendants knew of, or recklessly disregarded, significant problems in Fabric’s viability that would negatively impact GeneDx’s overall business and operations. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the GeneDx class action, go to https://www.rosenlegal.com/cases/genedx-holdings-corp/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9748897

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of Class A or Class C common stock of Zillow Group, Inc. (NASDAQ: ZG) (NASDAQ: Z) between February 11, 2025 and May 7, 2026, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026 in the securities class action first filed by the Firm.

SO WHAT: If you purchased Zillow common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Zillow class action, go to https://rosenlegal.com/cases/zillow-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Zillow’s agreement with Redfin Corporation was not a “partnership,” but rather an acquisition of Redfin’s business; (2) as a result of the Redfin Agreement, Zillow faced a materially heightened risk of regulatory scrutiny and liability under federal antitrust laws; (3) upon the filing of an antitrust lawsuit, Zillow continued to downplay its legal exposure; and (4) as a result, defendants’ statements about Zillow’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Zillow class action, go to https://rosenlegal.com/cases/zillow-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40^th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9748901

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Via Transportation, Inc. (NYSE: VIA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with Via’s initial public offering (the “IPO” or “Offering”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026.

SO WHAT: If you purchased Via common stock pursuant and/or traceable to the IPO you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Via class action, go to https://rosenlegal.com/cases/via-transportation-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the complaint, the Offering Documents used to effectuate Via’s IPO were false and misleading and omitted to state that, at the time of the IPO, Via’s growth had already begun to encounter obstacles because of Via’s declining Platform Annual Run-Rate Revenue and inability to grow in Germany. As these facts emerged after the IPO, Via shares fell sharply. By the commencement of this action, Via’s shares traded as low as $14.52, a decline of nearly 70% from the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Via class action, go to https://rosenlegal.com/cases/via-transportation-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9748877

        REGULATED INFORMATION

Publication relating to transparency notifications

Mont-Saint-Guibert (Belgium), June 17, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received transparency notifications as detailed below.

Robert Taub

On June 16, 2026, Nyxoah received a transparency notification from Robert Taub following an acquisition of voting securities by Robert Taub and Robelga SRL (an entity controlled by Robert Taub). Based on the notification, on June 10, 2026, Robert Taub (together with Robelga SRL) held 14,440,277 voting rights, representing 14.45% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284), and 50,000 equivalent financial instruments, representing 0.05% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 16, 2026 contains the following information:

• Reason for the notification: acquisition or disposal of voting securities or voting rights
• Notification by: a parent undertaking or a controlling person
• Persons subject to the notification requirement:
  • Robert Taub
  • Robelga SRL (with address at Avenue des Croix de Guerre 149 / 13, 1120 Brussels)
• Date on which the threshold was crossed: June 10, 2026
• Threshold that is crossed: 10%
• Denominator: 99,926,284
• Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Robert Taub	2,712,510	6,766,564		6.77%
Robelga SRL	1,598,290	7,673,713		7.68%
Subtotal	4,310,800	14,440,277		14.45%
	TOTAL	14,440,277	0	14.45%	0.00%

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
Robert Taub	Warrants	08/06/2027		25,000	0.03%	cash
Robert Taub	Warrants	14/06/2028		25,000	0.03%	cash
	TOTAL			50,000	0.05%

	TOTAL (A & B)			# of voting rights	% of voting rights
				14,490,277	14.50%

• Full chain of controlled undertakings through which the holding is effectively held: Robelga SRL is 100% owned by BMI Estate (a partnership (société simple) without legal personality). Robert Taub has 100% usufruct and Robert Taub’s children have 100% bare ownership of BMI Estate.

Pierre-Edouard Stérin

On June 17, 2026, Nyxoah received a transparency notification from Pierre-Edouard Stérin following an acquisition of voting securities by B.A.D. 21 SRL (an entity controlled by Pierre-Edouard Stérin). Based on the notification, on June 10, 2026, Pierre-Edouard Stérin (taking into account the holdings of his affiliates) held 7,221,666 voting rights, representing 7.23% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 17, 2026 contains the following information:

• Reason for the notification: acquisition or disposal of voting securities or voting rights
• Notification by: a parent undertaking or a controlling person
• Persons subject to the notification requirement:
  • Pierre-Edouard Stérin
  • Lemahieu Holding SRL (with address at Rue Haute 21, 1380 Lasne, Belgium)
  • Graal Holding SRL (with address at Rue Haute 21, 1380 Lasne, Belgium)
  • B.A.D. 21 SRL (with address at Rue Haute 21, 1380 Lasne, Belgium)
• Date on which the threshold was crossed: June 10, 2026
• Threshold that is crossed: 5%
• Denominator: 99,926,284
• Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Pierre-Edouard Stérin		0	0	0.00%	0.00%
Lemahieu Holding SRL		0	0	0.00%	0.00%
Graal Holding SRL		0	0	0.00%	0.00%
B.A.D. 21 SRL		7,221,666	0	7.23%	0.00%
Subtotal		7,221,666		7.23%
	TOTAL	7,221,666	0	7.23%	0.00%

• Full chain of controlled undertakings through which the holding is effectively held: B.A.D. 21 SRL is controlled by Graal Holding SRL, which itself is controlled by Lemahieu Holding SRL, which is controlled by Mr. Pierre-Edouard Stérin.

Cochlear Limited

On June 16, 2026, Nyxoah received a transparency notification from Cochlear Limited following the passive crossing of a threshold by Cochlear Investments Pty Ltd (an entity controlled by Cochlear Limited). Based on the notification, on June 10, 2026, Cochlear Limited (taking into account the holding of its affiliate) held 5,847,283 voting rights, representing 5.85% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 15, 2026 contains the following information:

• Reason for the notification: passive crossing of a threshold
• Notification by: a parent undertaking or a controlling person
• Persons subject to the notification requirement:
  • Cochlear Limited (with address at 1 University Avenue, Macquarie University, NSW 2109, Australia)
  • Cochlear Investments Pty Ltd (with address at 1 University Avenue, Macquarie University, NSW 2109, Australia)
• Date on which the threshold was crossed: June 10, 2026
• Threshold that is crossed: 10%
• Denominator: 99,926,284
• Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Cochlear Limited	0	0	0	0.00%	0.00%
Cochlear Investments Pty Ltd	5,631,319	5,847,283	0	5.85%	0.00%
Subtotal	5,631,319	5,847,283		5.85%
	TOTAL	5,847,283	0	5.85%	0.00%

• Full chain of controlled undertakings through which the holding is effectively held: Cochlear Investments Pty Ltd is a wholly owned subsidiary of Cochlear Limited, which is listed on the Australian Securities Exchange and has no controlling shareholder.
• Additional information: Cochlear Investments Pty Ltd acquired 215,964 ordinary shares in Nyxoah pursuant to a private placement completed on November 18, 2025, resulting in an increase of its shareholding to 5,847,283 ordinary shares which did not trigger any crossing of a threshold.

This notification concerns a downwards crossing of the 10% threshold following a passive decrease, whereby Cochlear Investments Pty Ltd’s holding in Nyxoah fell from 14.999% (as previously notified in September 2025) and 13.08% immediately prior to the capital increase, to 5.85% of the voting rights.
We understand the underwriters have been granted a 30-day option to subscribe for up to an additional 8,284,883 ordinary shares, which could further reduce Cochlear’s holding to 5.40% without crossing any additional disclosure threshold.

Gilde Healthcare Holding B.V.

On June 16, 2026, Nyxoah received a transparency notification from Gilde Healthcare Holding B.V. following the passive downward crossing of the lowest threshold.

The notification dated June 15, 2026 contains the following information:

• Reasons for the notification:
  • Passive crossing of a threshold
  • Downward crossing of the lowest threshold
• Notification by: a parent undertaking or a controlling person
• Persons subject to the notification requirement:
  • Gilde Healthcare Holding B.V. (with address at Stadsplateau 36, 3521 AZ Utrecht, the Netherlands)
  • Gilde Healthcare III Management B.V. (with address at Stadsplateau 36, 3521 AZ Utrecht, the Netherlands)
• Date on which the threshold was crossed: June 10, 2026
• Threshold that is crossed: 3%
• Denominator: 99,926,284
• Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Gilde Healthcare Holding B.V.
Gilde Healthcare III Management B.V.
	TOTAL

• Full chain of controlled undertakings through which the holding is effectively held: Gilde Healthcare III Management B.V. is controlled by Gilde Healthcare Holding B.V. Gilde Healthcare Holding B.V. is not a controlled entity.
• Additional information: Cooperatieve Gilde Healthcare III Sub-Holding UA and Cooperatieve Gilde Healthcare III Sub-Holding 2 UA hold the shares in Nyxoah. Gilde Healthcare III Management B.V. is the management company of these two entities, that in the absence of specific instructions can exercise the voting rights at its discretion.

Bank of America Corporation

On June 15, 2026, Nyxoah received a transparency notification from Bank of America Corporation following an acquisition of voting securities and of financial instruments that are treated as voting securities by entities that are controlled by Bank of America Corporation. Based on the notification, on June 10, 2026, Bank of America Corporation (taking into account the holdings of its affiliates) held 449,288 voting rights, representing 0.45% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284), and 2,971,370 equivalent financial instruments, representing 2.97% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 12, 2026 contains the following information:

• Reason for the notification:
  • Acquisition or disposal of voting securities or voting rights
  • Acquisition or disposal of financial instruments that are treated as voting securities
• Notification by: a parent undertaking or a controlling person
• Persons subject to the notification requirement:
  • Bank of America Corporation (with address at 1209 Orange Street – Corporation Trust Center, Wilmington DE 19801, United States of America)
• Date on which the threshold was crossed: June 10, 2026
• Threshold that is crossed: 3%
• Denominator: 99,926,284
• Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Bank of America Corporation		0		0.00%
Bank of America, National Association		7,319		0.01%
BofA Securities, Inc.		393,157		0.39%
Merrill Lynch International		48,812		0.05%
Subtotal		449,288		0.45%
	TOTAL	449,288	0	0.45%	0.00%

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
Merrill Lynch International	Right to recall			15,001	0.02%	physical
Merrill Lynch International	Rights of use			1	0.00%	physical
BofA Securities, Inc.	Rights of use			1,873,387	1.87%	physical
BofA Securities, Inc.	Right to recall			1,080,480	1.08%	physical
Bank of America, NA	Swap	15/10/2027		991	0.00%	cash
Merrill Lynch International	Swap	15/02/2028		519	0.00%	cash
Merrill Lynch International	Swap	15/10/2027		991	0.00%	cash
	TOTAL			2,971,370	2.97%

	TOTAL (A & B)			# of voting rights	% of voting rights
				3,420,658	3.42%

• Full chain of controlled undertakings through which the holding is effectively held: Bank of America, National Association, BofA Securities, Inc. and Merrill Lynch International are controlled by Bank of America Corporation. Bank of America Corporation is not a controlled entity.

Bank of America Corporation

On June 15, 2026, Nyxoah received a transparency notification from Bank of America Corporation following the disposal of voting securities and of financial instruments that are treated as voting securities by entities that are controlled by Bank of America Corporation resulting in the downward crossing of the lowest threshold. Based on the notification, on June 10, 2026, Bank of America Corporation (taking into account the holdings of its affiliates) held 269,166 voting rights, representing 0.27% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284), and 2,551,461 equivalent financial instruments, representing 2.55% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 15, 2026 contains the following information:

• Reason for the notification:
  • Downward crossing of the lowest threshold
  • Acquisition or disposal of voting securities or voting rights
  • Acquisition or disposal of financial instruments that are treated as voting securities
• Notification by: a parent undertaking or a controlling person
• Persons subject to the notification requirement:
  • Bank of America Corporation (with address at 1209 Orange Street – Corporation Trust Center, Wilmington DE 19801, United States of America)
• Date on which the threshold was crossed: June 11, 2026
• Threshold that is crossed: 3%
• Denominator: 99,926,284
• Notified details:

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Bank of America Corporation	0	0		0.00%
Bank of America, National Association	7,319	7,319		0.01%
BofA Securities, Inc.	393,157	216,277		0.22%
Merrill Lynch International	48,812	45,570		0.05%
Subtotal	449,288	269,166		0.27%
	TOTAL	269,166	0	0.27%	0.00%

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
Merrill Lynch International	Right to recall			15,000	0.02%	physical
BofA Securities, Inc.	Rights of use			1,445,424	1.45%	physical
BofA Securities, Inc.	Right to recall			1,088,536	1.09%	physical
Bank of America, NA	Swap	15/10/2027		991	0.00%	cash
Merrill Lynch International	Swap	15/02/2028		519	0.00%	cash
Merrill Lynch International	Swap	15/10/2027		991	0.00%	cash
	TOTAL			2,551,461	2.55%

	TOTAL (A & B)			# of voting rights	% of voting rights
				2,820,627	2.82%

• Full chain of controlled undertakings through which the holding is effectively held: Bank of America, National Association, BofA Securities, Inc. and Merrill Lynch International are controlled by Bank of America Corporation. Bank of America Corporation is not a controlled entity.

Contact:
Nyxoah
John Landry, CFO
[email protected]

Attachment

• 2026 06 17 PR Transparency notification (Robelga BAD21 Cochlear Gilde BofA) (ENG)

GlobeNewswire Distribution ID 1001188347

Non-dilutive debt funding complements the Company’s June equity raise, bringing total capital raised to $110 million

Mont-Saint-Guibert, Belgium – June 17, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA), today announced that it has received $15 million (€13.8 million) in proceeds from the second tranche of its loan facility with the European Investment Bank (EIB). The drawdown follows the recent confirmation that the Company had satisfied the predefined criteria required to access this tranche.

With this drawdown, Nyxoah has raised approximately $110 million in total new capital in June 2026, combining the proceeds of its underwritten public offering with this non-dilutive EIB financing.

The EIB proceeds are intended first and foremost to accelerate the commercial launch of Genio in the United States, while also supporting continued investment in research and development and the scale-up of manufacturing. As non-dilutive capital, the EIB financing reinforces the Company’s balance sheet without diluting existing shareholders.

“Receiving these funds from the European Investment Bank completes a transformative financing for Nyxoah,” said Olivier Taelman, Chief Executive Officer. “The EIB’s continued support is a strong endorsement of our technology and of the long-term potential of our mission to make sleep simple for OSA patients. This non-dilutive capital, alongside the equity proceeds raised this month, allows us to accelerate the commercial launch of Genio in the United States while continuing to invest in innovation. We are entering the next phase of our growth from a position of strength.”

About Nyxoah

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study and receipt of approval from the FDA for a subset of adult patients with moderate to severe OSA with an AHI of greater than or equal to 15 and less than or equal to 65.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. FDA approved in August 2025 as prescription-only device.

Forward-looking statements

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or management’s current expectations regarding the intended use of the proceeds under the second tranche of the European Investment Bank loan; the Company’s capital position; the Genio system; the potential advantages of the Genio system; and the Company’s commercialization strategy and growth in the U.S. market. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. These risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on March 26, 2026 and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:

Nyxoah

John Landry, CFO

[email protected]

Rémi Renard, Head of Investor Relations & Corporate Communication

[email protected]

Attachment

• ENGLISH_EIB Proceeds Received PR_DRAFT

GlobeNewswire Distribution ID 1001188313